Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Prepaid Assets (2023 - 2025)

CG Oncology's Prepaid Assets history spans 3 years, with the latest figure at $15.1 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 23.38% year-over-year to $15.1 million; the TTM value through Dec 2025 reached $15.1 million, up 23.38%, while the annual FY2025 figure was $15.1 million, 23.38% up from the prior year.
  • Prepaid Assets reached $15.1 million in Q4 2025 per CGON's latest filing, up from $13.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $15.1 million in Q4 2025 to a low of $6.4 million in Q4 2023.
  • Average Prepaid Assets over 3 years is $11.7 million, with a median of $11.9 million recorded in 2024.
  • Peak YoY movement for Prepaid Assets: surged 92.07% in 2024, then rose 3.88% in 2025.
  • A 3-year view of Prepaid Assets shows it stood at $6.4 million in 2023, then soared by 92.07% to $12.2 million in 2024, then grew by 23.38% to $15.1 million in 2025.
  • Per Business Quant, the three most recent readings for CGON's Prepaid Assets are $15.1 million (Q4 2025), $13.5 million (Q3 2025), and $11.4 million (Q2 2025).